| CPC score | mRS | Mortality 30 days | ||||||
---|---|---|---|---|---|---|---|---|---|
NfL cut-off 25Â pg/ml | NfL cut-off 50Â pg/ml | NfL cut-off 75Â pg/ml | NfL cut-off 25Â pg/ml | NfL cut-off 50Â pg/ml | NfL cut-off 75Â pg/ml | NfL cut-off 25Â pg/ml | NfL cut-off 50Â pg/ml | NfL cut-off 75Â pg/ml | |
Poor outcome/total per group | 12/43 | 15/38 | 71/83 | 16/43 | 21/38 | 74/83 | 8/43 | 15/38 | 68/83 |
Sensitivity Pr(+ A) | 87.80% | 72.40% | 61.20% | 85.60% | 66.70% | 55.00% | 91.20% | 74.70% | 63.70% |
Specificity Pr(− N) | 47.00% | 81.80% | 90.90% | 50.90% | 83.00% | 90.60% | 47.90% | 79.50% | 89.00% |
ROC area (sens. + spec.)/2 | 0.67 | 0.77 | 0.76 | 0.68 | 0.75 | 0.73 | 0.7 | 0.77 | 0.76 |
Likelihood ratio ( +) Pr(+ A)/Pr(+ N) | 1.65 | 3.98 | 6.73 | 1.74 | 3.93 | 5.83 | 1.75 | 3.64 | 5.82 |
Likelihood ratio (−) Pr(− A)/Pr(− N) | 0.26 | 0.34 | 0.43 | 0.28 | 0.4 | 0.5 | 0.18 | 0.32 | 0.41 |
Odds ratio LR( +)/LR(−) | 6.35 | 11.83 | 15.79 | 6.17 | 9.78 | 11.71 | 9.56 | 11.43 | 14.28 |
Positive predictive value Pr(A +) | 71.10% | 85.50% | 90.90% | 78.50% | 89.20% | 92.40% | 68.60% | 81.90% | 87.90% |
Negative predictive value Pr(N −) | 72.10% | 66.70% | 61.20% | 62.80% | 54.30% | 49.00% | 81.40% | 71.60% | 66.30% |